1-ACETYL-4-(2-HYDROXY-ETHYL)-PIPERAZINE HCL
![]() |
- $71 - $400
- Product name: 1-ACETYL-4-(2-HYDROXY-ETHYL)-PIPERAZINE HCL
- CAS: 1176419-58-1
- MF: C8H17ClN2O2
- MW: 208.69
- EINECS:
- MDL Number:MFCD08060482
- Synonyms:1-ACETYL-4-(2-HYDROXY-ETHYL)-PIPERAZINE HCL;1-ACETYL-4-(2-HYDROXYETHYL)PIPERAZINE HYDROCHLORIDE;1-(4-(2-Hydroxyethyl)piperazin-1-yl)ethanone HCL
4 prices
Selected condition:
Brand
- Alichem
- Chemenu
- Crysdot
Package
- 5g
- 10g
- 25g
- ManufacturerAlichem
- Product number1176419581
- Product description1-(4-(2-Hydroxyethyl)piperazin-1-yl)ethanonehydrochloride
- Packaging10g
- Price$400
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM168975
- Product description1-(4-(2-hydroxyethyl)piperazin-1-yl)ethan-1-onehydrochloride 95%+
- Packaging25g
- Price$71
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11340765
- Product description1-(4-(2-Hydroxyethyl)piperazin-1-yl)ethanonehydrochloride 95+%
- Packaging5g
- Price$119
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11340765
- Product description1-(4-(2-Hydroxyethyl)piperazin-1-yl)ethanonehydrochloride 95+%
- Packaging10g
- Price$198
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Alichem | 1176419581 | 1-(4-(2-Hydroxyethyl)piperazin-1-yl)ethanonehydrochloride | 10g | $400 | 2021-12-16 | Buy |
Chemenu | CM168975 | 1-(4-(2-hydroxyethyl)piperazin-1-yl)ethan-1-onehydrochloride 95%+ | 25g | $71 | 2021-12-16 | Buy |
Crysdot | CD11340765 | 1-(4-(2-Hydroxyethyl)piperazin-1-yl)ethanonehydrochloride 95+% | 5g | $119 | 2021-12-16 | Buy |
Crysdot | CD11340765 | 1-(4-(2-Hydroxyethyl)piperazin-1-yl)ethanonehydrochloride 95+% | 10g | $198 | 2021-12-16 | Buy |
Properties
storage temp. :Sealed in dry,Room Temperature
Safety Information
Symbol(GHS): |
![]() |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | ||||||||||||||||
Hazard statements: |
|
||||||||||||||||
Precautionary statements: |
|